1Wilkin J, Dahl M, Detmar M, et al. Standard grading system tbr rosacea: Report of the National Rosacea Society Expert Commit- tee on the classification and staging of rosaeea [J]. J Am Acad Dermatol, 2004, 50(6): 907-912.
2Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Cotllnlil-tee on the classification and staging of rosacea [J]. J Am Acad Dermatol, 2002, 46(4): 584-587.
6Fernandez-Obregon A.Oral use of azithromycin for the treatmen ofache rosacea[J].Arch Dennatol, 2004, 140(4): 489-490.
7Akhyani M, Ehsani AH, Ghiasi M, et al. Comparison of efficacy of azithromycin vs.doxycycline in the treatment of rosacea:a ran- domized open clinical trial[J]. Int J Dermatol, 2008, 47(3): 284- 288.
8Hofer T. Cominuous' microdos' isotretinoin in adult recalcitrant rosacea[J]. Clin Exp Dermatol, 2004, 29(2): 204-205.
1Buechner SA. Rosacea: An Update. Dermatology, 2005, 210(2): 100-108.
2Wilkin J, Dalai M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol, 2002, 46(4): 584-587.
3Crawford G, Pelle M, James W. Rosacea. I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol, 2004, 51 (3): 327-341.
4Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol, 2004, 50( 6 ): 907-912.
5PeUe MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol, 2004, 51(4): 499-512.
6Gollnick H, Layton A. Azelaic acid 15% gel in the treatment of rosacea. Expert Opin Pharmacother, 2008, 9( 15 ): 2699-2706.
7Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new reatment for papulopustular rosacea:Results from two vehicle-controlled, randomized phase IIl studies. J Am Acad Dermatol, 2003, 48(6): 836-845.
8Wolf JE Jr, Kerrouche N, Arsonnaud S. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. Cutis, 2006, 77 (4): 3-11.
9Thiboutot DM, Fleischer AB, Del Rosso JQ, et al. Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. J Drugs Dermatol, 2008, 7(6): 541-546.
10Del Rosso J. Evaluating the role of topical therapies in the management of rosacea: Focus on combination sodium sulfacetamide and sulfur formulations. Cutis, 2004, 73( 1 ): 29-33.
